An article published in Experimental Biology and Medicine (Volume 242, Issue 6, March, 2017) identifies a new signaling pathway involved in breast cancer cell growth. The study, led by Dr. Chan-Wha Kim, from the Department ...
Mar 30, 2017
0
7
One day, patients may be able to monitor their body's response to cancer therapy just by having their blood drawn. A new study, led by bioengineers at UC Berkeley, has taken an important step in that direction by measuring ...
Mar 24, 2017
0
48
A clinical trial of an antibody-drug conjugate that combines the active portion of a chemotherapy drug with an antibody targeting a molecule expressed on tumor cells appears promising for the treatment of metastatic triple-negative ...
Mar 14, 2017
0
2
For all the success of a new generation of immunotherapies for cancer, they often leave an entire branch of the immune system's disease-fighting forces untapped. Such therapies act on the adaptive immune system, the ranks ...
Mar 8, 2017
0
1186
A drug already used to slow tumor growth may also prevent infertility caused by standard chemotherapies, according to a study published online March 6 in the Proceedings of the National Academy of Sciences.
Mar 6, 2017
0
82
Ninety percent of cancer deaths are from cancer spread. Breast cancer patients, for example, typically do not die because cancer returns in their breast, they die because it spreads to other parts of their body. The most ...
Mar 2, 2017
0
15
The human immune system is powerful and complex. It can identify and destroy invaders of nearly infinite variety, yet spare the more than 30 trillion cells of the healthy body.
Feb 6, 2017
0
8
Breast cancer cells are evasive, finding ways to bypass drugs designed to stop their unchecked growth. In a new study, researchers uncovered a mechanism of resistance used by a particularly aggressive breast cancer type, ...
Jan 26, 2017
0
2
More than 100 women die from breast cancer every day in the United States. Triple-negative breast cancers, which comprise 15 to 20 percent of all breast tumors, are a particularly deadly type of breast disease that often ...
Jan 23, 2017
0
353
Scientists at the Medical University of South Carolina (MUSC) have designed an antibody-based therapy that could target the functions of TGF-beta that cause cancer. The therapy targets TGF-beta where it is particularly dangerous—docked ...
Jan 11, 2017
0
2
